Invivyd Inc. announced on March 22 that its monoclonal antibody, Pemgarda, had received emergency use authorization from the ...
The FDA has authorized Pemgarda, an infusion therapy that benefits people undergoing cancer treatment and organ transplant ...
The Food and Drug Administration just granted emergency use authorization for the drug, Pemgarda for those 12 and older.
Immunocompromised people get a new drug to protect against Covid-19 for the first time since the Omicron variants forced ...
The FDA has issued an emergency use authorization for Invivyd's new COVID-19 prevention drug Pemgarda, an infusion drug approved for use by patients who are immunocompromised.
There is no increased risk for stroke during the 6 weeks following receipt of either brand of the COVID-19 bivalent vaccine, ...
The World Health Organization has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how ...
More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug ...
Pemgarda was granted emergency use authorization for immunocompromised people 12 and older. The monoclonal antibody infusion may be available soon.
COVID-19 illness may include symptoms such as a sore throat, fever, cough, and fatigue. In January, the United States Centers ...
This is a KFF Health News story. Evangelical minister ... the National Foundation for Infectious Diseases. The drug Paxlovid against Covid-19 from the manufacturer Pfizer is stacked on a table ...
For vaccines and otherwise, focused and effective communication is at the heart of a successful public health response, ...